Drug Type TIL therapy |
Synonyms KSQ 004, KSQ004 |
Target |
Action modulators |
Mechanism SOCS1 modulators(suppressor of cytokine signaling 1 modulators), regnase-1 modulators(zinc finger CCCH-type containing 12A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | United States | ![]() | 10 Nov 2021 |